v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating Activities    
Net income (loss) $ 842 $ (13,698)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 1,038 932
Write-down of inventory 278 540
Deferred income taxes   784
Non-cash share-based compensation expense 277 257
Loss on sales of subsidiaries   13,708
Provision for (reversal of) allowance for doubtful accounts, net 16 (26)
Other, net 8 13
Changes in operating assets and liabilities:    
Accounts receivable (9,385) 2,356
Inventories (3,328) (2,791)
Other assets (324) (2,376)
Accounts payable 5,815 (2,363)
Accrued income taxes 536 (2,722)
Accrued and other liabilities 809 5,346
Contract liabilities 646 (950)
Net cash used in operating activities (2,772) (990)
Investing Activities    
Purchases of property, plant and equipment (790) (860)
Acquisition, net of cash and cash equivalents acquired (5,082)  
Net cash disposed of in sales of subsidiaries   (9,940)
Net cash used in investing activities (5,872) (10,800)
Financing Activities    
Proceeds from the exercise of stock options 1,148 799
Repurchase of common stock   (2,000)
Payments on long-term debt (284) (285)
Net cash provided by (used in) financing activities 864 (1,486)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (250) 578
Net Decrease in Cash, Cash Equivalents and Restricted Cash (8,030) (12,698)
Cash, Cash Equivalents and Restricted Cash, Beginning of Period [1] 45,070 59,134
Cash, Cash Equivalents and Restricted Cash, End of Period $ 37,040 $ 46,436
[1] Includes Cash, Cash Equivalents and Restricted Cash that are included in Held-For-Sale Assets on the Condensed Consolidated Balance Sheets for periods prior to January 22, 2020.

Source